Biotech Fund Doubles Down: Scholar Rock Bet Drives 26% Rally
A major biotech fund has increased its stake in Scholar Rock, increasing exposure to a platform that targets protein ...
Assess the pros and cons of emergency versus sinking funds to determine which is more suitable for your goals, and how to combine them effectively.
23,964 articlesA major biotech fund has increased its stake in Scholar Rock, increasing exposure to a platform that targets protein ...
A focused look at a large institutional bet on Indivior, the logic behind the $143 million investment, and how such m...
A leading biotech-focused fund just boosted its Immunome position by a material amount as the stock surged. This arti...
A Knicks star’s Broadway moment becomes a teachable moment for personal finance. Learn practical tips to fund experie...
When a celebrity moment goes beyond fashion, it becomes a teachable moment for money. This piece breaks down the fina...
A last-minute cancellation can hit wallets as hard as plans. This guide breaks down how to navigate refunds, recover ...
Treat your finances like a health reset. This article delivers four practical tips going financial cleanse to curb sp...
Two rising names—Oklo and Centrus Energy—are shaping the future of U.S. nuclear energy. This guide breaks down which ...
A newly released inspector general report into a Bridgeport shooting finds the pursuit justified but highlights ambul...
Choosing between a broad healthcare ETF and a biotech-focused fund can shape risk, cost, and growth. This guide break...
Unlock the habits that quietly compound wealth. This guide distills practical steps, real-world examples, and actiona...
When headlines hint at a fallout between two A-list friends, the impact isn’t just gossip. This article digs into the...